InFLAMES Flagship
Persons
Publications
- Validation of the individualized metabolic surgery score for bariatric procedure selection in the merged data of two randomized clinical trials (SLEEVEPASS and SM-BOSS) (2022)
- Validation of the Swiss-Finnish Bariatric Metabolic Outcome Score within a large prospective registry cohort (2025)
- Validity of fatty liver disease indices in the presence of alcohol consumption (2022)
- Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2023)
- Value of Ischemia in Prognosis and Guiding Revascularization Among Patients With Chronic Coronary Artery Disease (2024)





